All Talk, But Where's the Action?

Aug 31, 2011

There is certainly no shortage of ambition in the Chinese pharmaceutical industry, says In the Pipeline's Derek Lowe. But does it have the resources and wherewithal to follow through? China already has a substantial contract research industry, and it seems clear, Lowe says, that a Chinese Merck or a Chinese Novartis eventually will exist.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Best Options

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

A Butterfly's Wings

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

This Week in PNAS

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Pathogen Tracking

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Main menu